Adempa Tablet 25 mg contains Empagliflozin 25 mg, an oral antidiabetic medication used for the management of type 2 diabetes mellitus. It belongs to a class of medicines known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. Adempa helps lower blood sugar levels by promoting the removal of excess glucose from the body through urine.

Adempa is prescribed as part of a comprehensive diabetes care plan that includes dietary control, physical activity, and regular monitoring of blood glucose levels. It may be used alone or in combination with other antidiabetic agents when glycemic control is inadequate.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

• Empagliflozin 25 mg

Mechanism of Action

Empagliflozin works by inhibiting the SGLT2 protein in the kidneys. Under normal conditions, SGLT2 reabsorbs glucose back into the bloodstream. By blocking this transporter, Empagliflozin reduces glucose reabsorption and increases urinary glucose excretion.

As a result:

• Blood glucose levels decrease.

• Fasting and postprandial glucose levels improve.

• Caloric loss through urine may contribute to modest weight reduction.

• Osmotic diuresis may help reduce blood pressure in some patients.

This insulin-independent mechanism makes Adempa effective even in patients with insulin resistance.

Indications

Adempa Tablet 25 mg is indicated for:

• Management of Type 2 Diabetes Mellitus

• Improvement of glycemic control in adults inadequately controlled by diet and exercise

• Use as monotherapy or in combination with other oral antidiabetic drugs or insulin

• Reduction of cardiovascular risk in eligible patients with type 2 diabetes and established cardiovascular disease, as advised by a physician

Benefits

• Effective Glycemic Control: Lowers HbA1c and fasting blood glucose levels.

• Weight Management Support: May assist in modest weight reduction.

• Blood Pressure Reduction: Mild diuretic effect may help lower blood pressure.

• Cardiovascular Benefits: Demonstrated cardiovascular risk reduction in appropriate patients.

• Low Risk of Hypoglycemia: When used alone, as it does not stimulate insulin release.

Dosage and Administration

The usual recommended dose is 25 mg once daily, taken in the morning, with or without food. The dosage should be determined by a healthcare professional based on individual patient needs and kidney function.

Patients should maintain adequate hydration during therapy. Regular monitoring of blood glucose and renal function is advised.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• Not recommended for patients with Type 1 diabetes or diabetic ketoacidosis.

• Use with caution in patients with renal impairment.

• Increased risk of urinary tract infections and genital infections due to increased glucose in urine.

• May cause increased urination and mild dehydration.

• Rare cases of ketoacidosis have been reported; patients should seek medical attention if symptoms such as nausea, vomiting, abdominal pain, or difficulty breathing occur.

Adempa Tablet 25 mg should be used under medical supervision. Inform your healthcare provider about any existing medical conditions and other medications before starting treatment.